|
|
||||||||
Letters |
1
Groupe d'Etude des Substances Naturelles à Intérêt Thér., EA 491, Faculty of Pharmacy, Bordeaux, France ,
2
Centre d'Etudes et de Recherche sur les Xénobiot. , EA 1223, Faculty of Pharmacy, Poitiers, France
To the Editor:
Numerous epidemiological studies in France have shown a strong negative correlation between moderate red wine consumption and the incidence of cardiovascular disease (1)(2). Compared with other alcoholic beverages, red wine contains a much higher content of phenolic constituents. Frankel et al. (3) have shown that total phenolic compounds extracted from red wine inhibit the oxidation of human low-density lipoprotein (LDL) in vitro, which may provide an explanation for the "French paradox." In fact, increasing evidence suggests that oxidized LDL might be responsible for promoting atherogenesis.
Miller and Rice-Evans (4) examined a variety
Acknowledgments
Footnotes
References
The following articles in journals at HighWire Press have cited this article:
![]() |
S Prasad, N Kalra, S Srivastava, and Y Shukla Regulation of oxidative stress-mediated apoptosis by diallyl sulfide in DMBA-exposed Swiss mice Human and Experimental Toxicology, January 1, 2008; 27(1): 55 - 63. [Abstract] [PDF] |
||||
![]() |
L. Deluc, F. Barrieu, C. Marchive, V. Lauvergeat, A. Decendit, T. Richard, J.-P. Carde, J.-M. Merillon, and S. Hamdi Characterization of a Grapevine R2R3-MYB Transcription Factor That Regulates the Phenylpropanoid Pathway Plant Physiology, February 1, 2006; 140(2): 499 - 511. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |